6/30/2011 – UPDATE 7/1/2011 – Freedomisgreen.com obtained the new Department of Justice memo concerning medical marijuana. The communication is from US Deputy Attorney General James M. Cole. It was released on June 30th after New Jersey US Attorney Paul J. Fishman forwarded it to NJ state AG Paula Dow. The memo was sent to Dow in response to her multiple requests for federal clarification about medical marijuana operations authorized by state law.
4/29/2011 - The medical cannabis program enacted by the Garden State in January 2010 has not yet gone into practice. Now things have become even more complex. The first six permits for non-profit Alternative Treatments Centers were granted to groups with deep pockets and strong political influence. But that did not stop NJ Attorney General Paula Dow from sending a letter to the US Department of Justice asking for clarification.
The move last week put the nascent cannabis program in the federal government’s harsh spotlight. The April 22, 2011 letter states, in part:
As the state’s chief legal adviser to all of the departments in the Executive Branch, many of which are participating in carrying out the medical marijuana legislation, it is critical that I properly advise them as to the potential criminal and civil ramifications of their actions in carrying out their duties. [Read more...]
NJ Attorney General Paula Dow’s office sent a letter to US Attorney General Eric Holder late yesterday asking for clarification on the federal government’s stance on NJ’s medical marijuana program. Specifically, Dow’s letter inquired as to whether those licensed to grow or sell pot — as well as the state workers who will administer the program when it launches later this year — could face arrest.
“As the state’s chief legal adviser to all of the departments in the Executive Branch, many of which are participating in carrying out the medical marijuana legislation, it is critical that I properly advise them as to the potential criminal and civil ramifications of their actions in carrying out their duties,” according to Dow’s letter.
“Accordingly, I ask that you provide me with clear guidance as to the enforcement position of the Department of Justice relative to New Jersey’s medical marijuana legislation and the scope of the entities and individuals who may be subject to civil suit or criminal prosecution,” the letter said.
These legal questions potentially raise more obstacles to implementing an already delayed program.
Read more about New Jersey at www.cmmnj.org